PTX prescient therapeutics limited
Add to My Watchlist 2.27% ! 4.5¢

The pre-clinical and clinical data derived to date is always of...

  1. Shellbell
    8,345 Posts.
    lightbulb Created with Sketch. 3672
    clock Created with Sketch.
    25/06/25
    13:43
    Post #: 79562945
    The pre-clinical and clinical data derived to date is always of some value. Besides, continuing PTX-200 in the clinic for AML was seen as a less than prudent use of funds given the crowded AML space. Funds are best directed towards PTX-100, giving PTX a foot in the door towards commercialisation.

    The other thing to remember is that CellPryme is being kept going. It is a reiteration of PTX-200 for the enhancement of cell therapies, such as CAR-T. The evidence for our patent application just seems to grow: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2022241515

    When we hear anything about third-party evaluations (by way of a licensing deal) is anyone's guess. Last we heard, CellPryme-A was on its way into the clinic (or so I thought).
    Last edited by Shellbell: Wednesday, 13:44
    PTX Price at posting: 4.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 15  Upvote
    lightbulb Created with Sketch. 4  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Red Mountain to map, sample Quartz Reef after landing big alluvial nugget haul
right-arrow Created with Sketch.
NEWS How Do You Trade? Take Our 1-Minute Survey & Share Your Style
right-arrow Created with Sketch.
NEWS Profits after tax down -88%, and shares rocket – what's going on with Collins?
right-arrow Created with Sketch.
NEWS Uranium ignites: Is this the start of a supercycle?
right-arrow Created with Sketch.
NEWS Bullish Brookside expands with fifth DSU at 'highly sought after' American oil and gas field
right-arrow Created with Sketch.
NEWS Many Peaks accelerating gold hunt in Côte d'Ivoire after assay 'justification'
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
4.5¢ 		Change
0.001(2.27%) 		Mkt cap ! $36.23M
Open High Low Value Volume
4.5¢ 4.6¢ 4.5¢ $6.007K 133.4K

Buyers (Bids)

No. Vol. Price($)
3 480817 4.5¢
 

Sellers (Offers)

Price($) Vol. No.
4.6¢ 48908 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.